MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-PB-20-0012562
Signoret Pharmaceuticals Private Limited - pharma in Mohali, Punjab, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹3.5 Cr
▲ 17% YoY
Net profit · FY 2025
₹6.93 Lakh
Net margin 2%
EBITDA · FY 2025
₹38.73 Lakh
EBITDA margin 11.1%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹50 Lakh
Issued & subscribed
Open charges
₹1.5 Cr
Secured borrowings
Company age
7 yrs
Est. 2019
Directors on board
3
As per MCA filings
About Signoret Pharmaceuticals Private Limited
Data last updated:
Signoret Pharmaceuticals Private Limited is a private limited company based in Mohali, Punjab, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 February 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24290PB2019PTC049073. Its GSTIN is 03ABBCS6229E1ZO (Punjab).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors including Rajwinder Kaur and Simranjeet Singh.
Its last annual general meeting (AGM) was held on 14 November 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 556 Industrial Area Phase – 9, Mohali, Punjab, India – 160062.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.5 Cr, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹6.93 Lakh (net margin 2%) and EBITDA of ₹38.73 Lakh (EBITDA margin 11.1%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years.
The company is associated with 1 brand: Signoret Pharmaceuticals Private Limited. As per MCA filings, the company has open charges of ₹1.5 Cr on record. Court records list 5 cases involving the company, including 5 filed against it; 2 cases are pending.
Signoret Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-PB-20-0012562). For more details, the company can be reached via its website signoret.in.
Company details
CIN U24290PB2019PTC049073
Registration Number 049073
Incorporation Date 19 February 2019
ROC Chandigarh
Listing Status Unlisted
Company Status Active
MSME Classification Micro
Udyam Registration UDYAM-PB-20-0012562
Recognitions & Rankings of Signoret Pharmaceuticals
Contact details
Signoret Pharmaceuticals Private Limited's registered office is in Mohali, Punjab. Its website is signoret.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No. 556 Industrial Area Phase – 9, Mohali, Punjab, India – 160062
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Signoret Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Signoret Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Signoret Pharmaceuticals operates one associated brand: Signoret Pharmaceuticals Private Limited. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical operations and services based in Mohali, Punjab. | signoret.in |
Business activity
The main business activity of Signoret Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Signoret Pharmaceuticals Private Limited, buy the company report.
Financials of Signoret Pharmaceuticals Private Limited
FY 2025 filings availableSignoret Pharmaceuticals Private Limited reported revenue of ₹3.5 Cr (up 17% YoY) for FY 2025.
Revenue · FY 2025
₹3.5 Cr ▲ 17%
Net profit · FY 2025
₹6.93 Lakh margin 2%
EBITDA · FY 2025
₹38.73 Lakh margin 11.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 17%
3 years · compounded
▲ 14%
EBITDA CAGR growth
1 year
▲ 40%
3 years · compounded
▲ 6%
5 years · compounded
▲ 244%
Revenue has grown at a compounded annual rate (CAGR) of 14% over three years, including 17% growth in the latest year. EBITDA rose 40% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹38.73 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6.93 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.1% | ||||
| Net Profit Margin | 2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Signoret Pharmaceuticals Private Limited, buy the company report.
Board of directors of Signoret Pharmaceuticals Private Limited
Signoret Pharmaceuticals has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajwinder Kaur Also directs: Capcure Pharmaceuticals Private Limited | Director | 19 Feb 2019 | 7 Years 8 Months | Current |
| Simranjeet Singh | Director | 19 Feb 2019 | 7 Years 8 Months | Current |
| Jaswinder Singh Also directs: Capcure Pharmaceuticals Private Limited | Director | 12 Jun 2020 | 6 Years 5 Months | Current |
Auditor
Signoret Pharmaceuticals Private Limited is audited by SHIV BANSAL AND CO. for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SHIV BANSAL AND CO. | FY 2020 | 021339N |
Shareholding
The shareholding of Signoret Pharmaceuticals Private Limited is on record for FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Signoret Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1.5 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 15 Oct 2020 | 100402636 | Others | ₹1.5 Cr | Open |
Total charge records: 1 View all charges
Legal cases
Signoret Pharmaceuticals Private Limited has 5 court cases on record: 5 filed against it. 2 cases are pending and 3 are disposed.
Total cases
5
Filed against the company
5
Pending
2
Disposed
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 4 | 4 | 2 |
| District courts | 1 | 1 | 0 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, MAHARASHTRA | Court case (CRR) | Filed against the company by Sun Pharma Laboratories Limited | Pending |
| High Court, MAHARASHTRA | Court case (COMIP) | Filed against the company by Sun Pharma Laboratories Limited | Pending |
| High Court, MAHARASHTRA | Court case (LPETN) | Filed against the company by Sun Pharma Laboratories Limited | Disposed |
| High Court, MAHARASHTRA | Interim or miscellaneous application | Filed against the company by Sun Pharma Laboratories Limited | Disposed |
| District court, Chandigarh | Cheque dishonour complaint | Filed against the company by Tiwari Chemicals | Disposed |
To see the full case history of Signoret Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Signoret Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Signoret Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03ABBCS6229E1ZO | Punjab | Active | 08 Aug 2019 |
To see the full GST registrations and return filing status of Signoret Pharmaceuticals Private Limited, buy the company report.
Recent activity
Signoret Pharmaceuticals Private Limited has 3 board changes on record since 2019: 3 appointments. The latest: Jaswinder Singh was appointed as Director on 12 Jun 2020.
AGM
Signoret Pharmaceuticals Private Limited last Annual general meeting of members was held on 14 Nov 2025 as per latest MCA records.
Filing
Signoret Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Charges
A charge with Others amounted to Rs. 150.00 Lakh with Charge ID 100402636 was registered on 15 Oct 2020.
Appointed
Jaswinder Singh was appointed as Director.
Appointed
Rajwinder Kaur was appointed as Director.
Appointed
Simranjeet Singh was appointed as Director.
Incorporation
19 Feb 2019
Signoret Pharmaceuticals Private Limited was registered on 19 Feb 2019 with Roc Chandigarh & aged 7 years 8 months as per MCA records.
Frequently asked questions
Signoret Pharmaceuticals is an active private limited company based in Mohali, Punjab, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 February 2019 (7+ years old) and is registered under CIN U24290PB2019PTC049073.
Signoret Pharmaceuticals has 3 current directors:
- Rajwinder Kaur - Director
- Simranjeet Singh - Director
- Jaswinder Singh - Director
The latest financial statements of Signoret Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 14 November 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Signoret Pharmaceuticals is 03ABBCS6229E1ZO, registered in Punjab.
The CIN (Corporate Identification Number) of Signoret Pharmaceuticals is U24290PB2019PTC049073. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Signoret Pharmaceuticals has 5 court cases on record: 5 filed against it. 2 are pending. Most are in the high courts.
Signoret Pharmaceuticals was incorporated on 19 February 2019, making it 7+ years old. It is registered with the Registrar of Companies, Chandigarh.
Jaswinder Singh was appointed as Director on 12 Jun 2020. Rajwinder Kaur was appointed as Director on 19 Feb 2019. Simranjeet Singh was appointed as Director on 19 Feb 2019.
Yes, Signoret Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-PB-20-0012562).
Signoret Pharmaceuticals can be reached through the website signoret.in. Its registered office is in Mohali, Punjab, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages